Thursday, September 26, 2019 10:24:57 AM
_____________________________________________________________________________________________
Published: 23 August 2019
History and progress of hypotheses and clinical trials for Alzheimer’s disease (from Greenspam3)
https://www.nature.com/articles/s41392-019-0063-8
Comments on above:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150735844
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150738103
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150738889
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150739265
Eisai's PR on the Elenbecestat trial failure. (from Talon38)
http://eisai.mediaroom.com/2019-09-13-Eisai-And-Biogen-To-Discontinue-Phase-III-Clinical-Studies-Of-BACE-Inhibitor-Elenbecestat-In-Early-Alzheimers-Disease
The Drug industry's influence over research:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=142652537
How the Alzheimer’s Cabal Thwarted Research for 30 years! (from Biostockclub)
https://www.statnews.com/2019/06/25/alzheimers-cabal-thwarted-progress-toward-cure/
Why Big Pharma's plaque attack trials failed:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149743210
Commonly prescribed drugs are tied to nearly 50% higher dementia risk in older adults, study says (from kevli33).
https://www.cnn.com/2019/06/24/health/dementia-risk-drug-study/index.html
Is the Alzheimer's epidemic the result of bad pharma and bad psychiatry?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=142358853
Biogen needs something like us. Bad.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150304707
Takeda or Eisai?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621171
Eisai trying to emulate Anavex approach:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149720753
Eisai PR not behind paywall 6/13/18:
https://www.eisai.com/news/2018/news201847.html
Eisai’s AD pipeline...caving?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150096459
Changes at Eisai:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150051924
The “next wave” of BP’s being incubated now, in the form of small, smart, faster biotechs! 4/23/19 article:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148381829
Merck and 21st Century Medicine
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148109429
Merck and the Canadians team up:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148108335
https://www.eurekalert.org/pub_releases/2017-03/mu-npt031717.php
Roche and Genentech - a case study:
https://knowledge.wharton.upenn.edu/article/anatomy-of-a-merger-hostile-deals-become-friendly-in-the-end-right/
Why modern medicine is like the medieval church:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146539971
Below is a link to a 6-part article that shines a bright light on big pharma's influence in the market, research and fake news... rather revealing! (from basparks79)
https://articles.mercola.com/sites/articles/archive/2017/12/27/drug-safety-media-shaped-by-big-pharma.aspx
Biogen on the Brink
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150304707&txt2find=biogen
BIIB's problem with their Alzheimer's trial:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=144801572
Bayer also bailing on R&D:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=145174145
Why did Big Pharma bail on Alzheimer's trials early 2018? Possible Answer:
https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM596728.pdf
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=145205259
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=145214094
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=145215823
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=145214295
“Watch: How did the amyloid hypothesis go from promising to perilous in the search for Alzheimer’s treatments?”
By Damian Garde @damiangarde and Alex Hogan @hoganalex
May 21, 2019
(from kevli33)
https://www.statnews.com/2019/05/21/alzheimers-disease-amyloid-hypothesis-history/
(see also MS section)
Recent AVXL News
- Anavex Life Sciences Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before May 13, 2024 to Discuss Your Rights - AVXL • PR Newswire (US) • 05/03/2024 09:45:00 AM
- Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024 • GlobeNewswire Inc. • 05/02/2024 11:30:00 AM
- May 13, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against AVXL • PR Newswire (US) • 04/26/2024 09:45:00 AM
- Contact The Gross Law Firm by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL) • PR Newswire (US) • 04/19/2024 09:45:00 AM
- The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit - AVXL • PR Newswire (US) • 04/16/2024 09:45:00 AM
- Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 04/12/2024 09:45:00 AM
- Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference • GlobeNewswire Inc. • 04/11/2024 11:30:00 AM
- Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 04/09/2024 09:45:00 AM
- Anavex Life Sciences Corporation Class Action: The Gross Law Firm Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 - AVXL • PR Newswire (US) • 04/05/2024 09:45:00 AM
- Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL • PR Newswire (US) • 04/02/2024 09:45:00 AM
- Lost Money on Anavex Life Sciences Corporation(AVXL)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm • PR Newswire (US) • 03/29/2024 09:45:00 AM
- Investors who lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL • PR Newswire (US) • 03/26/2024 09:45:00 AM
- Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 03/25/2024 11:30:00 AM
- The Gross Law Firm Notifies Anavex Life Sciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline • PR Newswire (US) • 03/22/2024 09:45:00 AM
- Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia • GlobeNewswire Inc. • 03/18/2024 11:30:00 AM
- Anavex Life Sciences to Present at the 44th Annual TD Cowen Health Care Conference • GlobeNewswire Inc. • 02/26/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:05:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:04:32 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:04:31 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:03:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:03:06 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/07/2024 09:31:07 PM
- Anavex Life Sciences Reports Fiscal 2024 First Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/07/2024 12:30:00 PM
- Anavex Life Sciences to Announce Fiscal 2024 First Quarter Financial Results on Wednesday, February 7th, 2024 • GlobeNewswire Inc. • 02/01/2024 12:30:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/25/2024 10:01:34 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM